Academic History
Paola Neri, MD, PhD obtained her medical degree from Magna Græcia University, Catanzaro, Italy, where she also completed her specialty in Medical Oncology and obtained a PhD in Molecular Oncology and Experimental Immunology. She was then a Research Associate at the Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Dr Neri is now an Associate Professor of Medicine, attending physician in the Hematology division at the University of Calgary, Calgary, Canada, as well as a member of the Arnie Charbonneau Cancer Institute. She is also the Scientific Director of the Precision Oncology Hub, Translational Research Laboratory, at the Tom Baker Cancer Centre (TBCC), Calgary, Canada.
Speaking on the discovery of novel therapeutic targets for multiple myeloma
Dr Neri’s research is focused on the study of multiple myeloma (MM), and more particularly on discovering novel therapeutic targets through genomic studies looking at the genome signatures associated with MM cell response or resistance to anti-myeloma agents. She has received national and international grants from several agencies including the International Myeloma Society (IMS), Leukemia and Lymphoma Society (LLS), Multiple Myeloma Research Foundation (MMRF) and Canadian Institute of Health Research (CIHR).
